
The Naloxone Project
Opioid Resources & Help
Only for iPhone
Free · Designed for iPhone
iPhone
Everyone should know how to recognize an overdose, respond to an overdose, and administer naloxone to save a life. This app, curated by emergency and addiction physicians, is meant to educate the public and provide medically accurate, up-to-date information on opioid overdoses. It contains educational videos, graphics, and text that can guide you if an overdose is occurring before your very eyes. The information in this app can literally save a life! Moreover, the app has the ability for individuals to report overdoses and contribute to our understanding of overdose outcomes and contributing factors. If you are interested in or passionate about addressing the opioid overdose crisis, this app is for you!
OpiRescue provides information and a 5-step process for how to respond to an opioid overdose event. The guidelines that OpiRescue offers have been developed by the US Substance Abuse and Mental Health Services Administration (SAMHSA). Please seek a doctor’s advice in addition to using this app and before making any medical decisions.
Ratings & Reviews
Bug fixes and improvements
The developer, RxAssurance Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Location
- User Content
- Identifiers
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- RxAssurance Inc.
- Size
- 60.9 MB
- Category
- Health & Fitness
- Compatibility
Requires iOS 13.0 or later.
- iPhone
Requires iOS 13.0 or later. - iPod touch
Requires iOS 13.0 or later. - Mac
Requires macOS 11.0 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- Languages
- English
- Age Rating
18+
- 18+
- Contains
Health or Wellness Topics
- Copyright
- © 2024 RxAssurance Inc.